Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 97,675,640
  • Shares Outstanding, K 1,629,285
  • Annual Sales, $ 22,561 M
  • Annual Income, $ 4,920 M
  • 60-Month Beta 0.70
  • Price/Sales 4.30
  • Price/Cash Flow 13.57
  • Price/Book 5.46

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.94
  • Number of Estimates 5
  • High Estimate 1.16
  • Low Estimate 0.87
  • Prior Year 0.94
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.30 +8.41%
on 11/20/19
60.86 -1.50%
on 12/06/19
+2.99 (+5.25%)
since 11/06/19
3-Month
47.49 +26.24%
on 09/09/19
60.86 -1.50%
on 12/06/19
+11.68 (+24.20%)
since 09/06/19
52-Week
42.48 +41.13%
on 07/23/19
60.86 -1.50%
on 12/06/19
+6.70 (+12.58%)
since 12/06/18

Most Recent Stories

More News
Bristol-Myers Squibb Announces Studies Evaluating liso-cel in Multiple Additional Patient Populations, Site of Care and Disease Areas Presented at American Society of Hematology (ASH) Annual Meeting

--Preliminary data from the PILOT study showed promising efficacy and safety as second-line therapy in patients with aggressive relapsed or refractory large B-cell non-Hodgkin lymphoma who were transplant...

BMY : 59.95 (+0.79%)
Findings Released from Real-World Data Analysis of Eliquis (apixaban) for the Treatment of Venous Thromboembolism in Patients with Active Cancer

The Bristol-Myers Squibb-Pfizer Alliance today announced results from retrospective real-world data analyses reporting outcomes on the safety and effectiveness of Eliquis(R) (apixaban) compared to low...

BMY : 59.95 (+0.79%)
Bristol-Myers Squibb Announces Liso-Cel Met Primary and Secondary Endpoints in TRANSCEND NHL 001 Study

--Generally manageable safety profile with low incidence of CAR T-related severe cytokine release syndrome (CRS) and neurologic events

BMY : 59.95 (+0.79%)
Bristol-Myers Squibb and bluebird bio Announce Positive Top-line Results from the Pivotal Phase 2 KarMMa Study of Ide-cel in Relapsed and Refractory Multiple Myeloma

--Safety results are consistent with the data presented in CRB-401 study

BMY : 59.95 (+0.79%)
BLUE : 79.42 (-1.53%)
Bristol-Myers Squibb and Acceleron Pharma Provide Update on FDA Advisory Committee for Reblozyl(R) (luspatercept-aamt)

Bristol-Myers Squibb Company (NYSE: BMY) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that following the late-cycle review meeting on December 4, 2019, they were notified by the U.S. Food and...

BMY : 59.95 (+0.79%)
XLRN : 49.88 (+2.47%)
Bristol-Myer Sqb Rises 4.41% on Heavy Volume: Watch For Potential Pullback

Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $59.82 to a high of $60.17. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of...

BMY : 59.95 (+0.79%)
Bristol-Myer Sqb Set to Possibly Pullback After Yesterday's Rally of 4.41%

Bristol-Myer Sqb (NYSE:BMY) traded in a range yesterday that spanned from a low of $59.82 to a high of $60.17. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high of...

BMY : 59.95 (+0.79%)
Zacks.com featured highlights include: Target, Medtronic Public, Arconic, Science Applications International and Bristol-Myers Squibb

Zacks.com featured highlights include: Target, Medtronic Public, Arconic, Science Applications International and Bristol-Myers Squibb

SAIC : 84.84 (+1.04%)
BMY : 59.95 (+0.79%)
MDT : 113.09 (+0.79%)
ARNC : 31.02 (+1.77%)
TGT : 125.03 (+0.28%)
How Trading Your Own Retirement Can Fleece Your Financial Future - December 06, 2019

Achieving your retirement goals takes a much different investing approach than regular stock trading, from smartly managing risk to keeping emotions in check.

BMY : 59.95 (+0.79%)
LMT : 386.86 (+0.24%)
EQM : 21.86 (+1.49%)
Is iShares MSCI USA Equal Weighted ETF (EUSA) a Strong ETF Right Now?

Smart Beta ETF report for EUSA

EUSA : 62.68 (+0.86%)
BMY : 59.95 (+0.79%)
VTI : 160.29 (+0.89%)
ITOT : 71.20 (+0.84%)
GPN : 176.66 (-0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade BMY with:

Business Summary

Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious...

See More

Key Turning Points

2nd Resistance Point 61.25
1st Resistance Point 60.60
Last Price 59.95
1st Support Level 59.56
2nd Support Level 59.17

See More

52-Week High 60.86
Last Price 59.95
Fibonacci 61.8% 53.84
Fibonacci 50% 51.67
Fibonacci 38.2% 49.50
52-Week Low 42.48

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar